Search Results
Search for other papers by Ryan A Lafferty in
Google Scholar
PubMed
Search for other papers by Laura M McShane in
Google Scholar
PubMed
Search for other papers by Zara J Franklin in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Finbarr P M O’Harte in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Introduction It has been well established that abnormal elevation in circulating glucagon leads to an increase in hepatic glucose production and glycogen metabolism that contribute to hyperglycaemia in diabetes ( Unger 1978 ). For this reason
Search for other papers by James C Needell in
Google Scholar
PubMed
Search for other papers by Madalyn N Brown in
Google Scholar
PubMed
Search for other papers by Danny Zipris in
Google Scholar
PubMed
Introduction Type 1 diabetes (T1D) is a proinflammatory progressive disease thought to be triggered by both genetic and environmental factors ( Atkinson et al . 2014 ). There is evidence supporting the notion that viruses are key players in
Mercy Perinatal Research Centre, University of Queensland Centre for Clinical Research, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Heidelberg, Victoria, Australia
Search for other papers by Karen Oliva in
Google Scholar
PubMed
Mercy Perinatal Research Centre, University of Queensland Centre for Clinical Research, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Heidelberg, Victoria, Australia
Search for other papers by Gillian Barker in
Google Scholar
PubMed
Search for other papers by Gregory E Rice in
Google Scholar
PubMed
Search for other papers by Mark J Bailey in
Google Scholar
PubMed
Mercy Perinatal Research Centre, University of Queensland Centre for Clinical Research, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, Heidelberg, Victoria, Australia
Search for other papers by Martha Lappas in
Google Scholar
PubMed
Introduction The prevalence of type 2 diabetes is increasing rapidly. Alarmingly, it is predicted that ∼350 million people worldwide will be diagnosed with type 2 diabetes by the year 2030, double the current number ( Wild et al . 2004
Search for other papers by Christy M Gliniak in
Google Scholar
PubMed
Search for other papers by Line Pedersen in
Google Scholar
PubMed
Search for other papers by Philipp E Scherer in
Google Scholar
PubMed
diabetes, cardiovascular disease, stroke, hypertension, and cancer. Obesity is, by definition, an excess of fat mass. However, the pathogenesis of obesity involves processes that are more complex than the simple accumulation of fat. Adipose tissue biology
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Cid Pitombo in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Eliana P Araújo in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Cláudio T De Souza in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by José C Pareja in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Bruno Geloneze in
Google Scholar
PubMed
Surgery, State University of Campinas, UNICAMP, 13083-970, Campinas, Brazil
Department of Surgery, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Search for other papers by Lício A Velloso in
Google Scholar
PubMed
Introduction Visceral adiposity is one of the main risk factors for the development of insulin resistance, diabetes mellitus, hypertension, and cardiovascular disease ( Ferrannini et al. 1997 , Fujimoto et al. 1999 ). The
Search for other papers by Yi Lin in
Google Scholar
PubMed
Search for other papers by Zhongjie Sun in
Google Scholar
PubMed
patients with type I diabetes and 5–10% of patients with type II diabetes eventually develop ESRD ( Ruggenenti & Remuzzi 1998 , Lin & Sun 2010 a ). Conventional therapies such as strict glycemic control and antihypertensive treatment do not completely stop
Search for other papers by Hongying An in
Google Scholar
PubMed
Search for other papers by Ling He in
Google Scholar
PubMed
Metformin, a time-proven effective agent for the treatment of patients with type 2 diabetes In the medieval Europe, the Gallega officinalis plant was used as a folk medicine to treat diabetes. In the late 1800s, the plant was found to be rich in
Search for other papers by Julie Takada in
Google Scholar
PubMed
Search for other papers by Miriam Helena Fonseca-Alaniz in
Google Scholar
PubMed
Search for other papers by Tarcila Beatriz Ferraz de Campos in
Google Scholar
PubMed
Search for other papers by Sandra Andreotti in
Google Scholar
PubMed
Search for other papers by Amanda Baron Campana in
Google Scholar
PubMed
Search for other papers by Maristela Okamoto in
Google Scholar
PubMed
Search for other papers by Cristina das Neves Borges-Silva in
Google Scholar
PubMed
Search for other papers by Ubiratan Fabres Machado in
Google Scholar
PubMed
Search for other papers by Fabio Bessa Lima in
Google Scholar
PubMed
Introduction Hyperglycemia in diabetes mellitus (DM) is a result of inadequate insulin secretion and reduced systemic responsiveness to insulin ( DeFronzo et al . 1992 ). Obesity, most notably central adiposity, is one of the main features of the
Search for other papers by L van Bloemendaal in
Google Scholar
PubMed
Search for other papers by J S ten Kulve in
Google Scholar
PubMed
Search for other papers by S E la Fleur in
Google Scholar
PubMed
Search for other papers by R G Ijzerman in
Google Scholar
PubMed
Search for other papers by M Diamant in
Google Scholar
PubMed
Introduction Obesity and type 2 diabetes mellitus (T2DM), also termed ‘diabesity’, are major public health problems due to their pandemic occurrence ( Whiting et al . 2011 , Flegal et al . 2012 ) and their association with adverse consequences
Search for other papers by Elisabet Estil.les in
Google Scholar
PubMed
Laboratory of Diabetes and Experimental Endocrinology, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Endocrine Unit (13-2), Department of Clinical Sciences, IDIBELL-University of Barcelona, Feixa Llarga s/n 08907 L'Hospitalet de Llobregat, Barcelona, Spain
Search for other papers by Noèlia Téllez in
Google Scholar
PubMed
Laboratory of Diabetes and Experimental Endocrinology, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Endocrine Unit (13-2), Department of Clinical Sciences, IDIBELL-University of Barcelona, Feixa Llarga s/n 08907 L'Hospitalet de Llobregat, Barcelona, Spain
Laboratory of Diabetes and Experimental Endocrinology, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Endocrine Unit (13-2), Department of Clinical Sciences, IDIBELL-University of Barcelona, Feixa Llarga s/n 08907 L'Hospitalet de Llobregat, Barcelona, Spain
Search for other papers by Joan Soler in
Google Scholar
PubMed
Laboratory of Diabetes and Experimental Endocrinology, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Endocrine Unit (13-2), Department of Clinical Sciences, IDIBELL-University of Barcelona, Feixa Llarga s/n 08907 L'Hospitalet de Llobregat, Barcelona, Spain
Laboratory of Diabetes and Experimental Endocrinology, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Endocrine Unit (13-2), Department of Clinical Sciences, IDIBELL-University of Barcelona, Feixa Llarga s/n 08907 L'Hospitalet de Llobregat, Barcelona, Spain
Search for other papers by Eduard Montanya in
Google Scholar
PubMed
Introduction β-Cell mass reduction has a central role in the development of type 1 and type 2 diabetes, and in both conditions the loss of β-cells has been largely attributed to increased β-cell death ( Butler et al . 2003 , Devendra et al . 2004